Bloomberg reports that US-based Pfizer could hike its bid for UK-based Astrazeneca to $106 billion from $90 billion has added a few pips to cable. The pound rose last week when news of the bid was first revealed.
Bloomberg reports that US-based Pfizer could hike its bid for UK-based Astrazeneca to $106 billion from $90 billion has added a few pips to cable. The pound rose last week when news of the bid was first revealed.
Most Popular
Sponsored
MEOH surged 95% but faces risks; PCJ liquidates $10.5M amid net loss.
April CPI likely up 0.6%, annual inflation hits 3.7%. Fed rates steady, oil prices fuel costs.
EL beats EPS estimates, raises guidance. Fragrance & China drive growth, but margins dip. Buy?
Oil jumps on US-Iran tensions. Chip stocks lift US markets to records, but ceasefire hopes fade.
Oil prices surge on shortages! FANG & DVN yield 15%+ but risk 25% downside. CVX offers steady 3.9% yield.
investingLive Asia-Pacific FX news wrap: Oil and the USD held firm, US-Iran pessimism
AKAM beats revenue, raises EPS guidance despite lower Q2 outlook. AI deals boost future growth.
Sponsored